Aerovate Therapeutics, Inc. (AVTE)
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Address
930 WINTER STREET
WALTHAM, MA 02451
Founded
2018
Number of Employees
51
Website
http://www.aerovatetx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)